Novus progressus - Company finances
|
EUR
|
2024
From: 2024-01-23
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 4,615 | 10,535 |
| Profit before tax | -485 | 594 |
| Net profit | -485 | 583 |
| Equity | -85 | 498 |
| Liabilities | 3,054 | 2,826 |
| Non-current assets | 2,429 | 1,959 |
| Current assets | 540 | 1,365 |
| Total assets | 2,969 | 3,324 |
|
Taxes paid
|
||
| STI taxes | 390 | 623 |
|
Financial indicators
|
||
| Revenue change y/y | - | +128.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -16.3% | 17.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 117.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -10.5% | 5.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -10.5% | 5.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 5.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Novus progressus - Social security debts
The amount of overdue SODRA debt for the company Novus progressus as of the last working day is: 161 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-14 | 160.96 |
| 2026-09-01 | 2026-09-02 | 160.96 |
| 2026-08-26 | 2026-08-31 | 80.48 |
| 2026-08-23 | 2026-08-23 | 80.48 |
| 2026-08-19 | 2026-08-19 | 80.48 |
| 2026-08-16 | 2026-08-17 | 80.48 |
| 2026-08-01 | 2026-08-14 | 80.48 |
| 2026-07-01 | 2026-07-31 | 241.44 |
| 2026-06-02 | 2026-06-30 | 160.96 |
| 2026-05-03 | 2026-06-01 | 80.48 |
| 2026-04-01 | 2026-04-30 | 241.44 |
| 2026-03-03 | 2026-03-31 | 160.96 |
| 2026-02-03 | 2026-03-02 | 80.48 |
| 2024-03-01 | 2024-04-30 | 64.50 |
Novus progressus - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Novus progressus is: 55 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 55.23 |
| 2026-08-31 | 2026-08-31 | 54.92 |
| 2026-08-14 | 2026-08-30 | 54.76 |
| 2026-08-06 | 2026-08-13 | 0.05 |
| 2026-08-02 | 2026-08-05 | 49.78 |
| 2026-07-09 | 2026-08-01 | 49.31 |
| 2026-07-02 | 2026-07-08 | 0.76 |
| 2026-06-30 | 2026-07-01 | 72.75 |
| 2026-06-18 | 2026-06-29 | 72.29 |
| 2026-04-30 | 2026-06-17 | 0.4 |
| 2026-04-17 | 2026-04-29 | 0.32 |
| 2026-03-20 | 2026-03-27 | 49.19 |
| 2026-03-18 | 2026-03-18 | 48.86 |
| 2026-03-11 | 2026-03-17 | 0.33 |
| 2026-03-02 | 2026-03-10 | 112.6 |
| 2026-02-21 | 2026-03-01 | 112.33 |
| 2026-02-13 | 2026-02-20 | 0.27 |
| 2026-01-22 | 2026-02-03 | 0.04 |
| 2026-01-20 | 2026-01-21 | 97.89 |
| 2026-01-16 | 2026-01-19 | 97.35 |
| 2025-12-17 | 2026-01-15 | 0.29 |
| 2025-10-26 | 2025-12-16 | 0.07 |
| 2025-10-18 | 2025-10-22 | 48.55 |
| 2025-09-19 | 2025-10-17 | 0.02 |
| 2025-09-05 | 2025-09-18 | 0.04 |
| 2025-09-01 | 2025-09-04 | 48.73 |
| 2025-08-28 | 2025-08-31 | 48.6 |
| 2025-08-01 | 2025-08-27 | 0.07 |
| 2025-07-18 | 2025-07-22 | 48.68 |
| 2025-07-16 | 2025-07-17 | 0.15 |
| 2025-07-02 | 2025-07-15 | 0.14 |
| 2025-07-01 | 2025-07-01 | 48.74 |
| 2025-06-19 | 2025-06-30 | 48.6 |
| 2025-05-28 | 2025-06-18 | 0.07 |
| 2025-05-17 | 2025-05-20 | 48.91 |
| 2025-05-07 | 2025-05-16 | 48.61 |
| 2025-03-26 | 2025-05-06 | 0.08 |
| 2025-03-20 | 2025-03-25 | 48.54 |
| 2025-02-26 | 2025-03-19 | 0.01 |
| 2025-02-25 | 2025-02-25 | 48.6 |
| 2025-02-22 | 2025-02-24 | 48.53 |
| 2025-02-20 | 2025-02-20 | 75.0 |
| 2025-02-02 | 2025-02-02 | 48.69 |
| 2025-01-18 | 2025-02-01 | 48.53 |
| 2024-12-19 | 2024-12-19 | 97.67 |
| 2024-11-01 | 2024-12-18 | 0.61 |
| 2024-10-12 | 2024-10-31 | 48.93 |
| 2024-08-21 | 2024-10-11 | 0.4 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Novus progressus, MB (code 306667295) is a Lithuanian small partnership operating in other human health activities n.e.c. In the latest financial year, 2025, the company generated revenue of €10.5K, which was 128.3% higher than in 2024, when revenue was €4.6K. Profitability also improved: net profit reached €583 in 2025 after a net loss of €485 in 2024, and the profit margin moved to 5.5% from -10.5%. The balance sheet remained small but strengthened slightly during the year. Total assets stood at €3.3K, equity at €498 and liabilities at €2.8K. Long-term assets amounted to €2.0K, while short-term assets were €1.4K. Key ratios show a high return on equity of 117.1% and return on assets of 17.5%, both influenced by the limited equity base. Debt to equity was 5.67 and the equity ratio was 15.0%, indicating that liabilities still exceed own funds. Asset turnover reached 3.17x in 2025, reflecting stronger use of the asset base alongside revenue growth.